C\/EBP_NN
activates_VBZ
the_DT
human_JJ
corticotropin-releasing_JJ
hormone_NN
gene_NN
promoter_NN
._.

The_DT
purpose_NN
of_IN
these_DT
studies_NNS
was_VBD
to_TO
identify_VB
whether_IN
transcription_NN
factors_NNS
,_,
associated_VBN
with_IN
cytokine_NN
signalling_NN
,_,
affected_VBD
promoter_NN
activity_NN
of_IN
the_DT
corticotropin_NN
releasing_NN
hormone_NN
-LRB-_-LRB-
CRH_NN
-RRB-_-RRB-
gene_NN
._.

Fragments_NNS
of_IN
a_DT
3.6_CD
kb_NN
sequence_NN
of_IN
the_DT
human_JJ
CRH_NN
gene_NN
promoter_NN
were_VBD
amplified_VBN
by_IN
PCR_NN
and_CC
ligated_VBN
upstream_JJ
of_IN
a_DT
CAT_NN
reporter_NN
._.

These_DT
constructs_NNS
were_VBD
transfected_VBN
into_IN
a_DT
variety_NN
of_IN
cell_NN
lines_NNS
,_,
either_CC
alone_RB
or_CC
together_RB
,_,
with_IN
transcription_NN
factor_NN
expression_NN
vectors_NNS
._.

Basal_JJ
activity_NN
of_IN
a_DT
3070_JJ
bp_NN
CRH_NN
promoter_NN
fragment_NN
was_VBD
only_RB
seen_VBN
in_IN
neuronal_JJ
and_CC
lymphoblastoid_JJ
cell_NN
lines_NNS
._.

Promoter_NN
activity_NN
was_VBD
increased_VBN
by_IN
the_DT
transcription_NN
factors_NNS
C\/EBPbeta_NN
-LRB-_-LRB-
NF-IL6_NN
-RRB-_-RRB-
and_CC
more_RBR
strongly_RB
,_,
by_IN
C\/EBPdelta_NN
-LRB-_-LRB-
NF-IL6beta_NN
-RRB-_-RRB-
._.

Increased_VBN
CRH_NN
promoter_NN
activity_NN
following_VBG
phorbol_NN
ester_NN
treatment_NN
was_VBD
inhibited_VBN
by_IN
a_DT
dominant_JJ
negative_JJ
NF-IL6_NN
mutant_NN
,_,
showing_VBG
that_IN
the_DT
effects_NNS
of_IN
phorbol_NN
ester_NN
were_VBD
principally_RB
mediated_VBN
by_IN
C\/EBP_NN
._.

Moreover_RB
,_,
the_DT
inverse_JJ
changes_NNS
in_IN
the_DT
expression_NN
of_IN
CRH_NN
in_IN
the_DT
hypothalamus_NN
and_CC
spleens_NNS
of_IN
arthritic_JJ
rats_NNS
were_VBD
paralleled_VBN
by_IN
similar_JJ
inverse_JJ
changes_NNS
in_IN
NF-IL6beta_NN
expression_NN
in_IN
these_DT
organs_NNS
._.

These_DT
data_NNS
show_VBP
that_IN
some_DT
transcription_NN
factors_NNS
associated_VBN
with_IN
cytokine_NN
signalling_NN
can_MD
also_RB
activate_VB
the_DT
CRH_NN
promoter_NN
._.

